Advanced search
Publication Cover
Bioengineered Volume 10, 2019 - Issue 1
Submit an article Journal homepage
1,666
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation in vitro and in nude mouse xenografts

Chunlei Gea Department of Cancer Biotherapy Center, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan, ChinaView further author information
,
Baozhen Zenga Department of Cancer Biotherapy Center, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan, ChinaView further author information
,
Ruilei Lia Department of Cancer Biotherapy Center, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan, ChinaView further author information
,
Zhen Lia Department of Cancer Biotherapy Center, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan, ChinaView further author information
,
Qiaofen Fua Department of Cancer Biotherapy Center, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan, ChinaView further author information
,
Weiwei Wangb Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan, ChinaView further author information
,
Zhenyu Wangc Department of Biomedical Engineering Research Center, Kunming Medical University, Kunming, Yunnan, ChinaView further author information
,
Suwei Donga Department of Cancer Biotherapy Center, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan, ChinaView further author information
,
Zhangchao Laia Department of Cancer Biotherapy Center, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan, ChinaView further author information
,
Ying Wanga Department of Cancer Biotherapy Center, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan, ChinaView further author information
,
Yuanbo Xuea Department of Cancer Biotherapy Center, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan, ChinaView further author information
,
Jiyin Guoa Department of Cancer Biotherapy Center, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan, ChinaView further author information
,
Tiannan Dia Department of Cancer Biotherapy Center, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan, ChinaView further author information
&
Xin Songa Department of Cancer Biotherapy Center, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, Yunnan, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 425-436 | Received 23 Jul 2019, Accepted 09 Sep 2019, Published online: 28 Sep 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Qingjun Meng, Yanguang Li, Zhen Sun & Xue Yang. (2022) CircRNA hsa_circ_0070659 predicts poor prognosis and promotes non-small cell lung cancer (NSCLC) progression via microRNA-377 (miR-377) / Ras-Associated Binding Protein 3C (RAB3C) pathway. Bioengineered 13:6, pages 14578-14594.
Read now
Yuan Gao, Yukun Tang, Qian Sun, Guixue Guan, Xiaoyan Wu, Fan Shi, Zihao Zhou & Wen Yang. (2021) Circular RNA FOXP1 relieves trophoblastic cell dysfunction in recurrent pregnancy loss via the miR-143-3p/S100A11 cascade. Bioengineered 12:1, pages 9081-9093.
Read now
Cheng Wang, Miaomiao Yang, Xi Gu & Yanjing Gu. (2021) Lemur tyrosine kinase-3 (LMTK3) induces chemoresistance to cetuximab in colorectal cancer via the ERK/MAPK pathway. Bioengineered 12:1, pages 6594-6605.
Read now

Articles from other publishers (6)

Yaoshuai Zhang, Yongping Li, Yuehua Han, Min Li, Xian Li, Fangtian Fan, Hao Liu & Shanshan Li. (2023) Experimental study of EGFR-TKI aumolertinib combined with ionizing radiation in EGFR mutated NSCLC brain metastases tumor. European Journal of Pharmacology 945, pages 175571.
Crossref
Liqin Zhang, Shuya Bing, Mo Dong, Xiaoqiu Lu & Yuancheng Xiong. (2021) Targeting ion channels for the treatment of lung cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:2, pages 188629.
Crossref
Lei Zhu, Yuqin Zheng, Tao Wu, Jiaxing He, Xiongchao Fang, Shuai Zhou, Ke Wang & Nan Wang. (2021) Immune-related genes STIM1, ITPKC and PELI1 polymorphisms are associated with risk of colorectal cancer. European Journal of Cancer Prevention 30:5, pages 357-363.
Crossref
Aarushi Sharma, Grace T. Ramena & Randolph C. Elble. (2021) Advances in Intracellular Calcium Signaling Reveal Untapped Targets for Cancer Therapy. Biomedicines 9:9, pages 1077.
Crossref
Manh Tien Tran. (2021) Overview of Ca2+ signaling in lung cancer progression and metastatic lung cancer with bone metastasis. Exploration of Targeted Anti-tumor Therapy.
Crossref
Ilaria Guerriero, Gianni Monaco, Vincenzo Coppola & Arturo Orlacchio. (2020) Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy. Pharmaceuticals 13:11, pages 413.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.